A case of the accumulation of 131-iodine in the mammary gland after remnant ablation for papillary thyroid carcinoma on lactating period.

作者信息

Murayama Daisuke, Yamamoto Yayoi, Matsui Ai, Yasukawa Mio, Toda Soji, Iwasaki Hiroyuki

机构信息

Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakao Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.

Department of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, 2-3-2 Nakao Asahi-ku Yokohama, Kanagawa 241-8515, Japan.

出版信息

Radiol Case Rep. 2021 Sep 5;16(11):3442-3444. doi: 10.1016/j.radcr.2021.08.035. eCollection 2021 Nov.

DOI:10.1016/j.radcr.2021.08.035

PMID:34527119

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8429622/

Abstract

The accumulation of 131-iodine is known to occur in the extrathyroidal tissues, such as the salivary glands and the gastrointestinal tract during radioactive iodine therapy. It is considered to be due to the expression of sodium iodide symporter. A 36-year-old lactating female was treated for remnant ablation for papillary thyroid carcinoma (pT1bN1bM0 pStage I) on the condition that she refrained from breastfeeding and was separated from her child and was milked to promote the excretion of 131-iodine until the accumulation disappeared on scintigram imaging. Scintigram showed the decrease and disappearance of the 131-iodine accumulation and the external dose rate was measured and confirmed to have decreased on the day 7 and 14 after the treatment. In conclusion, remnant ablation may be available by milking and separation from the child for 7 to 14 days.

摘要